Neoplasm associated with expression of a RET (REarranged during Transfection) fusion. RET fusion-positive tumors have been identified in a broad range of solid tumor types, including multiple endocrin...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
AUM Biosciences Pty Ltd.
Other
ArsNova Partners, LLC
Other
Bayer HealthCare Pharmaceuticals Inc.
Other
Catalytica Pharmaceuticals, Inc
Other
Helsinn Healthcare SA
Other
Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company
Other
Rigel Pharmaceuticals, Inc.
Other
Sanofi-Synthelabo Research
Other